Open Access Articles- Top Results for Fibrin
Journal of Vascular Medicine & SurgeryPrompt Recanalizaton of Basilar Artery (Lazarus Effect) in Patient with Acute Ischemic Cardioembolic Stroke in Spite of Relatively Late Start of Fibr
JBR Journal of Interdisciplinary Medicine and Dental ScienceUse of Fibrin Sealant in Guided Tissue Regeneration of Intrabony Defect
Journal of Cell Science & TherapyFibrin-Targeting, Peptide Amphiphile Micelles as Contrast Agents for Molecular MRI
Journal of Tissue Science & EngineeringEndothelial Cell Lining of PET Vascular Prostheses: Modification with Degradable Polyester-based Copolymers and Adhesive Protein Multi-layers
Journal of Blood Disorders & TransfusionFibrinogen Maracaibo: Hypo-Dysfibrinogenemia Caused by a Heterozygous Mutation in the Gen that Encodes for the Fibrinogen Aα Chain (G.1194G>A:
Fibrin (also called Factor Ia) is a fibrous, non-globular protein involved in the clotting of blood. It is formed by the action of the protease thrombin on fibrinogen which causes the latter to polymerize. The polymerized fibrin together with platelets forms a hemostatic plug or clot over a wound site.
When the lining of a blood vessel is broken, platelets are attracted forming a platelet plug. These platelets express thrombin receptors on their surfaces that bind serum thrombin molecules which in turn convert soluble fibrinogen in the serum into fibrin at the wound site. Fibrin forms long strands of tough insoluble protein that are laid down and are bound to the platelets. Factor XIII completes the cross-linking of fibrin so that it hardens and contracts. The cross-linked fibrin forms a mesh overlying the platelet plug that completes the clot.
Role in disease
Excessive generation of fibrin due to activation of the coagulation cascade leads to thrombosis, the block of a vessel by an agglutination of red blood cells, platelets, polymerized fibrin and other components. Ineffective generation or premature lysis of fibrin predisposes to hemorrhage.
Dysfunction or disease of the liver can lead to a decrease in the production of fibrin's inactive precursor, fibrinogen, or to the production of abnormal fibrinogen molecules with reduced activity (dysfibrinogenaemia). Hereditary abnormalities of fibrinogen (the gene is carried on chromosome 4) are of both quantitative and qualitative in nature and include afibrinogenaemia, hypofibrinogenaemia, dysfibrinogenaemia, and hypodysfibrinogenaemia.
Consequences of reduced, absent, or dysfunctional fibrin is likely to render patients as hemophiliacs.
Fibrin from different animal sources is generally glycosylated with complex type biantennary asparagine linked glycans. Variety is found in the degree of core fucosylation and in the type of sialic acid and galactose linkage.
The image at the left is a crystal structure of the double-d fragment from human fibrin with two bound ligands. The experimental method used to obtain the image was X-ray diffraction, and it has a resolution of 2.30 Å. The structure is mainly made up of single alpha helices shown in red and beta sheets shown in yellow. The two blue structures are the bound ligands. The chemical structures of the ligands are Ca+2 ion, alpha-D-mannose (C6H12O6), and D-glucosamine (C8H15NO6).
- Kehrel BE (2003). "[Blood platelets: biochemistry and physiology]". Hamostaseologie (in German) 23 (4): 149–58. PMID 14603379. doi:10.1267/Hamo03040149.
- Pabst M, Bondili JS, Stadlmann J, Mach L, Altmann F (July 2007). "Mass + retention time = structure: a strategy for the analysis of N-glycans by carbon LC-ESI-MS and its application to fibrin N-glycans". Anal. Chem. 79 (13): 5051–7. PMID 17539604. doi:10.1021/ac070363i.
- TGW1916.net, Defibrinated blood harvested from sheep (video)
- Fibrin: Molecule of the Month, by David Goodsell, RCSB Protein Data Bank
Lua error in Module:Authority_control at line 346: attempt to index field 'wikibase' (a nil value).